Strategic partnerships Fondazione Telethon actively collaborates with biotech and pharma partners (eg Can-Fite, AGC Biologics, AAVantgarde Bio) to advance gene therapy and rare disease programs, signaling openness to collaboration on funded or co-developed projects that leverage their research expertise.

Gene therapy focus The organization’s mission centers on gene therapy and genetic disease research, including initiatives around WAS and Lowe Syndrome, presenting opportunities to offer contract research, manufacturing support, plasmid DNA services, and gene delivery platform collaborations.

Global expansion signals Recent press shows active engagement with international partners and translational programs (US commercial launch collaborations, TIGEM and SR-Tiget postdoctoral initiatives), indicating a growing need for scalable research infrastructure, pilot programs, and talent pipelines.

Funding and scale With substantial research funding history (hundreds of millions invested) and revenue in the low-to-mid tens of millions, Telethon represents a sizable, mission-driven customer with potential demand for advanced analytics, data platforms, and secure collaboration tools to manage large research portfolios.

Technical stack readiness Usage of cloud, analytics, and security tools (AWS, Adobe Experience Cloud, Matomo, Piwik PRO Core, KnowBe4) suggests familiarity with modern tech ecosystems, making them receptive to integrated SaaS solutions for research data management, compliance, and digital outreach.